Skip to main content

and
  1. No Access

    Article

    Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

    This dose-effect study extends previous observations showing that psilocybin can occasion mystical-type experiences having persisting positive effects on attitudes, mood, and behavior.

    Roland R. Griffiths, Matthew W. Johnson, William A. Richards in Psychopharmacology (2011)

  2. Article

    Erratum: Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

    Correction to: Neuropsychopharmacology (2006) 31, 2639–2651. doi:10.1038/sj.npp.1301031; published online 25 January 2006. There are some errors in the figures of the above referenced paper that require correc...

    Tao **e, Liqiong Tong, Michael W McLane, George Hatzidimitriou in Neuropsychopharmacology (2008)

  3. Article

    Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

    We studied in vivo expression of the serotonin transporter (SERT) protein after 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine (PCA), or fenfluramine (FEN) treatments, and compared the effects of s...

    Tao **e, Liqiong Tong, Michael W McLane, George Hatzidimitriou in Neuropsychopharmacology (2006)

  4. No Access

    Article

    Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder

    J. Benjamin, Marilla Geraci, Una McCann, Benjamin D. Greenberg in Psychopharmacology (1999)

  5. No Access

    Article

    Caffeine reversal of sleep deprivation effects on alertness and mood

    This study assessed the ability of high doses of caffeine to reverse changes in alertness and mood produced by prolonged sleep deprivation. Fifty healthy, nonsmoking males between the ages of 18 and 32 served ...

    David Penetar, Una McCann, David Thorne, Gary Kamimori in Psychopharmacology (1993)

  6. No Access

    Article

    Comparison of the daytime sleep and performance effects of zolpidem versus triazolam

    Fifty healthy male subjects were administered zolpidem (5, 10, or 20 mg), triazolam (0.5 mg) or placebo, then attempted to sleep in a non-sleep-conductive environment. Subjects were awakened at 90 min post-dru...

    Thomas J. Balkin, Vincent M. O'Donnell, Nancy Wesensten, Una McCann in Psychopharmacology (1992)